PMDA — authorised 23 March 2021
- Marketing authorisation holder: Incyte Biosciences Japan GK
- Status: approved
🇯🇵 Pemazyre in Japan
PMDA authorised Pemazyre on 23 March 2021
Marketing authorisation
Pemazyre in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Japan
Frequently asked questions
Is Pemazyre approved in Japan?
Yes. PMDA authorised it on 23 March 2021.
Who is the marketing authorisation holder for Pemazyre in Japan?
Incyte Biosciences Japan GK holds the Japanese marketing authorisation.